Amount Raised
$16 Million
Round Type
Funding Round
San FranciscoBiotechnologyDescription
GT Biopharma, Inc. (NASDAQ: GTBP), an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKETM) technology platform is pleased to announce the company has raised over $16 million in proceeds from the exercise of warrants. The warrants were issued as part of the $27 million financing that closed in February 2021.
Quick answer
GT Biopharma raised $16 Million in a Funding Round round, dated July 28, 2021. GT Biopharma is based in San Francisco, California, United States.
- How much did GT Biopharma raise?
- GT Biopharma raised $16 Million in a Funding Round round on July 28, 2021.
- What does GT Biopharma do?
- GT Biopharma is a biotechnology company developing novel immuno-oncology biopharmaceutical drugs using its proprietary NK cell engager (TriKE) platform technology.
- Where is GT Biopharma based and how big is it?
- GT Biopharma is based in San Francisco, California, United States. Fundz records about 8 employees.
- Who are the decision-makers at GT Biopharma?
- Fundz holds 1 contact at GT Biopharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as GT Biopharma that raised within 45 days of this round, from Fundz verified event records.
- AVITUS ORTHOPAEDICS, INC. raised $5M on September 10, 2021.
- IntelGenx Technologies Corp. raised $2.1M (Seed) on September 10, 2021.
- Nectero Medical Inc raised $20M (Series C) on September 10, 2021.
- Whitehawk Therapeutics, Inc. raised $155M on September 10, 2021.
- Eclipsebio raised $12M on September 10, 2021.
- Obsidian Therapeutics raised $115M (Series B) on September 9, 2021.
Who to call at GT Biopharma, and when
A new round usually means GT Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GT Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GT Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GT Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GT Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
GT Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.